Squarepoint
MBII

Squarepoint’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Squarepoint’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,663
Closed -$16K – 3813
2020
Q4 		$16K Buy
+12,663
New +$15.1K ﹤0.01% 2842
2020
Q1 		– Sell
-22,447
Closed -$23K – 2753
2019
Q4 		$23K Buy
+22,447
New +$27.2K ﹤0.01% 2424

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Squarepoint's MBII Position: Q1 2021 in Review

Squarepoint sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2021, closing a stake of 12,663 shares — an estimated $16K sold.

Squarepoint first reported a position in MBII in Q4 2019 and held it in 2 quarters. The position peaked at $23K in Q4 2019. 74 funds tracked by Wall St. Rank hold MBII as of Q1 2021.

  • Squarepoint reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 12,663 Marrone Bio Innovations, Inc. shares in Q1 2021, an estimated $16K.
  • Squarepoint first reported a position in Marrone Bio Innovations, Inc. in Q4 2019 and held it in 2 quarters.
  • Squarepoint's Marrone Bio Innovations, Inc. position peaked at $23K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.